| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA680952 | F | Ability to inhibit the dibutyryl-cAMP-induced change of an immature glioma cell to a mature, differentiated astrocyte by in vitro astrocytoma assay at 100 ug/mL dose (Experiment #1) value may range from 51 to 70 | Mus musculus | 1 | ALA1123608 | assay format | Scientific Literature | |
| 2. | ALA681100 | F | Ability to inhibit the dibutyryl-cAMP-induced change of an immature glioma cell to a mature, differentiated astrocyte by in vitro astrocytoma assay at 100 ug/mL dose (Experiment #2) value may range from 31 to 50 | Mus musculus | 1 | ALA1123608 | assay format | Scientific Literature | |
| 3. | ALA682580 | F | Ability to inhibit the dibutyryl-cAMP-induced change of an immature glioma cell to a mature, differentiated astrocyte by in vitro astrocytoma assay at 10 ug/mL dose (Experiment #1) value may range from 6 to 15 | Mus musculus | 1 | ALA1123608 | assay format | Scientific Literature | |
| 4. | ALA682722 | F | Ability to inhibit the dibutyryl-cAMP-induced change of an immature glioma cell to a mature, differentiated astrocyte by in vitro astrocytoma assay at 10 ug/mL dose (Experiment #2) value may range from 31 to 50 | Mus musculus | 1 | ALA1123608 | assay format | Scientific Literature | |
| 5. | ALA682728 | F | Ability to inhibit the dibutyryl-cAMP-induced change of an immature glioma cell to a mature, differentiated astrocyte by in vitro astrocytoma assay at 1 ug/mL dose (Experiment #1) value may range from 0 to 5 | Mus musculus | 1 | ALA1123608 | assay format | Scientific Literature | |
| 6. | ALA682729 | F | Ability to inhibit the dibutyryl-cAMP-induced change of an immature glioma cell to a mature, differentiated astrocyte by in vitro astrocytoma assay at 1 ug/mL dose (Experiment #2) value may range from 0 to 5 | Mus musculus | 1 | ALA1123608 | assay format | Scientific Literature | |
| 7. | ALA719570 | F | The percent increase in life span on P388 cells which were inoculated intraperitoneally in CD2F1 mice at 200 mg/kg dose placed at ranking order 1 | Mus musculus | 2 | ALA1123608 | organism-based format | Scientific Literature | |
| 8. | ALA719715 | F | The percent increase in life span on P388 cells which were inoculated intraperitoneally in CD2F1 mice at 200 mg/kg dose placed at ranking order 3 | Mus musculus | 3 | ALA1123608 | organism-based format | Scientific Literature | |
| 9. | ALA719720 | F | The percent increase in life span on P388 cells which were inoculated intraperitoneally in CD2F1 mice at 400 mg/kg (tested in the same control) dose placed at ranking order 4 | Mus musculus | 2 | ALA1123608 | organism-based format | Scientific Literature | |
| 10. | ALA721836 | F | The percent increase in life span on P388 cells which were inoculated intraperitoneally in CD2F1 mice at 800 mg/kg dose placed at ranking order 2 | Mus musculus | 1 | ALA1123608 | organism-based format | Scientific Literature | |
| 11. | ALA719911 | F | In vivo antitumor activity against the B16 melanoma cell line expressed as percent increase in life span at 100 mg/kg dose | Mus musculus | 2 | ALA1123608 | organism-based format | Scientific Literature | |
| 12. | ALA719914 | F | In vivo antitumor activity against the B16 melanoma cell line expressed as percent increase in life span at 200 mg/kg dose | Mus musculus | 2 | ALA1123608 | organism-based format | Scientific Literature | |
| 13. | ALA719919 | F | In vivo antitumor activity against the L1210 leukemia cell line expressed as percent increase in life span at 200 mg/kg dose | Mus musculus | 3 | ALA1123608 | organism-based format | Scientific Literature | |
| 14. | ALA719920 | F | In vivo antitumor activity against the L1210 leukemia cell line expressed as percent increase in life span at 400 mg/kg dose | Mus musculus | 1 | ALA1123608 | organism-based format | Scientific Literature | |
| 15. | ALA719926 | F | In vivo antitumor activity against the M5076 reticulum cell sarcoma expressed as percent increase in life span at 400 mg/kg dose | Mus musculus | 1 | ALA1123608 | organism-based format | Scientific Literature | |
| 16. | ALA722357 | F | In vivo antitumor activity against the M5076 reticulum cell sarcoma expressed as percent increase in life span at 800 mg/kg doseEach represents a pair of experiments performed with the same control group | Mus musculus | 1 | ALA1123608 | organism-based format | Scientific Literature | |
| 17. | ALA723698 | F | Percent increase in life span (ILS) was measured on P388 cells which were inoculated intraperitoneally in CD2F1 mice | Mus musculus | 10 | ALA1123608 | organism-based format | Scientific Literature | |
| 18. | ALA1963976 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | 27,593 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 19. | ALA1963981 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | 41,327 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 20. | ALA1963985 | F | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | 41,631 | ALA1201862 | cell-based format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!